Allergy Therapeutics PLC (LSE:AGY) - Share price - Overview

Stock Report

Allergy Therapeutics PLC AGY

Last Price
GBX25.50

Day Change
-0.75|-2.86%

As of 25/05/2018
16:38:43 BST | GBX
Minimum 15 Minutes Delay.

Last Close26.25p
Day Range25.00 - 25.80
Mkt Cap151.50Mil
52-Wk Range23.00 - 39.50
Yield %-
ISINGB00B02LCQ05
Volume337,368
P/E-60.71
P/S0.02
P/CF8.50

Share Price

Total Returns 25/05/2018

 Chg (%)  
More ...
Allergy Therapeutics PLC2.00 
FTSE 100 TR GBP5.34
 
Financials
201520162017
More ...
Income Statement
Turnover43.2348.5164.14
Operating Profit0.73-11.95-1.90
Net Profit0.11-13.07-2.48
Reported EPS0.02-2.29-0.42
Balance Sheet
Current Assets33.7937.6137.46
Non Current Assets16.9119.0719.72
Total Assets50.7056.6857.18
Current Liabilities7.4212.5214.02
Total Liabilities16.2326.3627.22
Total Equity34.4730.3229.97
Cash Flow
Operating Cash Flow3.30-11.931.28
Net Change in Cash20.54-0.79-1.95
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
15/03/2018PurchaseDr. Babatunde Adekunle Otulana0.3925,0009,700.00
11/10/2017PurchaseDr. Babatunde Adekunle Otulana0.5125,00012,665.00

Company Profile

Allergy Therapeutics PLC is a pharmaceutical products company. It develops therapies for allergy based diseases, having its primary market in Germany.

Sector

Drug Manufacturers - Major

Index

FTSE AIM All-Share

Next Event 28/09/2018

Final Results
Ratios
Comp
More ...
PER (E)0.00
Div Yld (E)0.00
PEG (E)0.00
ROCE-4.04
Op Mrgn-0.03
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorDr. Babatunde Adekunle Otulana
Non-Executive Director, ChairmanMr. Peter Sinclair Jensen
Non-Executive DirectorMr. Stephen Rushworth Smith
Executive Director, Chief Executive OfficerMr. Manuel Llobet
Executive Director, Finance DirectorMr. Nicolas Alexander Ulrich Wykeman
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.